May 05, 2025 8:00 am EDT Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
Apr 30, 2025 4:05 pm EDT Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
Apr 21, 2025 8:00 pm EDT Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
Feb 26, 2025 8:30 am EST Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
Jan 22, 2025 8:30 am EST Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Nov 19, 2024 7:30 am EST Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
Nov 14, 2024 4:15 pm EST Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
Nov 04, 2024 7:30 am EST Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement